|
Exchange Disseminated Time | With reference to the news item appearing in Economic Times on May 21, 2015 titled "Cadila eyes Claris Arm for Rs. 3400Cr", Claris Lifesciences Ltd has Clarified to BSE as under :
"As a company policy we do not comments on any market rumour and speculations. The Company continues to explore and evaluate inorganic and strategic opportunities in various forms from time to time; however nothing definitive in this regard has happened. We will notify the exchanges upon occurrence of any definitive developments in this regard.
Also as a company we inform stock exchange for any such information which is required under listing agreement as well as clause 36 of the listing agreement." |
|
|